Lonze, B E <br/><br/>
Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Feb 2014 
 - 459-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.12540  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antiphospholipid Syndrome--etiology<br/>Complement Inactivating Agents--therapeutic use<br/>Follow-Up Studies<br/>Graft Rejection--etiology<br/>Humans<br/>Kidney Failure, Chronic--complications<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Postoperative Complications--prevention & control<br/>Prognosis<br/>Prospective Studies<br/>Recurrence<br/>Remission Induction